Abstract:figure legend We determined how physiological extremes of O2 and CO2 impact redox regulation of cerebral bioenergetic function. World‐class breath‐hold divers performed two maximal apnoeas resulting in hypoxaemic hypercapnia (prior normoxic normoventilation) and hyperoxaemic hypercapnia (prior hyperoxic hyperventilation). Transcerebral exchange of ascorbate free radicals (A•−) and nitric oxide metabolites were calculated as the product of global cerebral blood flow (gCBF) and radial arterial (a) to internal jugular venous (v) concentration gradients. Cerebral output (v > a) of A•− was enhanced in hypoxaemic hypercapnia and coincided with greater suppression of plasma nitrite (NO2−) uptake (a > v), gCBF and cerebral metabolic rate of glucose (gCMRGlu), implying reduced consumption and delivery of NO consistent with elevated cerebral oxidative–nitrosative stress (OXNOS). Abbreviations: ICA, internal carotid artery; MCA, middle cerebral artery; PCA, posterior cerebral artery; VA, vertebral artery. Summary interpretation: these findings highlight a key catalytic role for hypoxaemia in cerebral OXNOS, with NO2− reduction most probably serving as the dominant vasoactive mechanism. Figure created using Biorender (https://biorender.com/). We examined the extent to which apnoea‐induced extremes of oxygen demand/carbon dioxide production impact redox regulation of cerebral bioenergetic function. Ten ultra‐elite apnoeists (six men and four women) performed two maximal dry apnoeas preceded by normoxic normoventilation, resulting in severe end‐apnoea hypoxaemic hypercapnia, and hyperoxic hyperventilation designed to ablate hypoxaemia, resulting in hyperoxaemic hypercapnia. Transcerebral exchange of ascorbate radicals (by electron paramagnetic resonance spectroscopy) and nitric oxide metabolites (by tri‐iodide chemiluminescence) were calculated as the product of global cerebral blood flow (by duplex ultrasound) and radial arterial (a) to internal jugular venous (v) concentration gradients. Apnoea duration increased from 306 ± 62 s during hypoxaemic hypercapnia to 959 ± 201 s in hyperoxaemic hypercapnia (P ≤ 0.001). Apnoea generally increased global cerebral blood flow (all P ≤ 0.001) but was insufficient to prevent a reduction in the cerebral metabolic rates of oxygen and glucose (P = 0.015–0.044). This was associated with a general net cerebral output (v > a) of ascorbate radicals that was greater in hypoxaemic hypercapnia (P = 0.046 vs. hyperoxaemic hypercapnia) and coincided with a selective suppression in plasma nitrite uptake (a > v) and global cerebral blood flow (P = 0.034 to <0.001 vs. hyperoxaemic hypercapnia), implying reduced consumption and delivery of nitric oxide consistent with elevated cerebral oxidative–nitrosative stress. In contrast, we failed to observe equidirectional gradients consistent with S‐nitrosohaemoglobin consumption and plasma S‐nitrosothiol delivery during apnoea (all P ≥ 0.05). Collectively, these findings highlight a key catalytic role for hypoxaemic hypercapnia in cerebral oxidative–nitrosative stress. Key points Local sampling of blood across the cerebral circulation in ultra‐elite apnoeists determined the extent to which severe end‐apnoea hypoxaemic hypercapnia (prior normoxic normoventilation) and hyperoxaemic hypercapnia (prior hyperoxic hyperventilation) impact free radical‐mediated nitric oxide bioavailability and global cerebral bioenergetic function. Apnoea generally increased the net cerebral output of free radicals and suppressed plasma nitrite consumption, thereby reducing delivery of nitric oxide consistent with elevated oxidative–nitrosative stress. The apnoea‐induced elevation in global cerebral blood flow was insufficient to prevent a reduction in the cerebral metabolic rates of oxygen and glucose. Cerebral oxidative–nitrosative stress was greater during hypoxaemic hypercapnia compared with hyperoxaemic hypercapnia and coincided with a lower apnoea‐induced elevation in global cerebral blood flow, highlighting a key catalytic role for hypoxaemia. This applied model of voluntary human asphyxia might have broader implications for the management and treatment of neurological diseases characterized by extremes of oxygen demand and carbon dioxide production.

Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry

Characteristics and Feasibility of Ambulatory Respiratory Assessment of Paediatric Neuromuscular Disease: an Observational Retrospective Study.

Assessing air travel safety in neuromuscular disease: standard versus prolonged hypoxic challenge tests

"De Novo" Hypercapnic Respiratory Failure Unmasking Neuromuscular Disorders: Experiences From a Tertiary Care Center and Review of Literature

Getting It Right in Restrictive Lung Disease

Effective non-invasive ventilation reduces muscle sympathetic nerve activity in patients with stable hypercapnic COPD

Is Hypercapnia Associated with Poor Prognosis in Chronic Obstructive Pulmonary Disease? A Long-Term Follow-Up Cohort Study.

Association between rate of change in PaCO2 and functional outcome for patients with hypercapnia after out-of-hospital cardiac arrest: Secondary analysis of a randomized clinical trial

Hypercapnia and lung function parameters in chronic obstructive pulmonary disease

The role of noninvasive ventilation in the management of type II respiratory failure in patients with myotonic dystrophy

Determining the effects of elevated partial pressure of oxygen on hypercapnia-induced cerebrovascular reactivity

Hyperoxemia in invasively ventilated COVID-19 patients-Insights from the PRoVENT-COVID study

Does PaCO2 correction have an impact on survival of patients with chronic respiratory failure and long-term non-invasive ventilation?

Oximetry and carbon dioxide screening for ventilatory requirements in children with spinal muscular atrophy type 1-3

Influence of hypercapnia and hypercapnic hypoxia on the heart rate response to apnea

A Narrative Review of the Physiological Rationale and Clinical Evidence

[Application of capnography and SpO2 measurement in the evaluation of respiratory failure in patients with chronic obstructive pulmonary disease]

Efficacy of High-Flow Nasal Cannula Oxygen Therapy in Patients with Mild Hypercapnia

Determinants of usage and nonadherence to noninvasive ventilation in children and adults with Duchenne muscular dystrophy

Severe hypoxaemic hypercapnia compounds cerebral oxidative–nitrosative stress during extreme apnoea: Implications for cerebral bioenergetic function

Is hypocapnia a risk factor for non-invasive ventilation failure in cardiogenic acute pulmonary edema?